STTK Shattuck Labs, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 11, 2026
$6.73
· % 处于52周区间
· 高于低点
· 至高点
$1.7052周低点
$8.3352周高点
市值 (MRQ)
$678M
P/E (TTM)
-15.3
EPS (TTM)
$-0.44
收入 (TTM)
$1M
STTK 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$6.73
市值 (MRQ)
$678M
P/E (TTM)
-15.3
EPS (TTM)
$-0.44
收入 (TTM)
$1M
ROE (TTM)
-39.2%
52周区间
$2–$8
STTK 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$1M2019-12-31 → 2025-12-31
EPS$-0.702020-12-31 → 2025-12-31
自由现金流$-40M2020-12-31 → 2025-12-31
净利率-5256.8%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | STTK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -15.35年均值 ≈-3.7 | ≈-3.7 | · | · | |
| P/S (TTM) | 677.95年均值 ≈149.0 | ≈149.0 | 54.5 | 估值过高 | |
| 市净率 (MRQ) | 3.25年均值 ≈1.8 | ≈1.8 | 2.9 | 估值过高 | |
| Price / FCF (股价/自由现金流) | -10.75年均值 ≈-4.1 | ≈-4.1 | · | · | |
| Price / Cash Flow (市现率) | -10.75年均值 ≈-4.3 | ≈-4.3 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 5.25年均值 ≈1.5 | ≈1.5 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | STTK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -5578.7%5年均值 ≈-6674.8% | ≈-6674.8% | -1056.2% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -4780.8%5年均值 ≈-6401.9% | ≈-6401.9% | -1056.2% | 弱 | |
| 净利润率 (TTM) | -5256.8%5年均值 ≈-6483.7% | ≈-6483.7% | -1000.6% | 弱 | |
| ROA (TTM) | -36.9%5年均值 ≈-39.0% | ≈-39.0% | -33.0% | 弱 | |
| ROE (TTM) | -39.2%5年均值 ≈-52.3% | ≈-52.3% | -39.4% | 弱 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | STTK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 27.65年均值 ≈10.8 | ≈10.8 | 8.9 | 流动性强 | |
| Quick Ratio (速动比率) | 7.75年均值 ≈6.1 | ≈6.1 | 5.8 | 流动性强 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | STTK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -82.5%5年均值 ≈84.2% | ≈84.2% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 15.3%5年均值 ≈-24.0% | ≈-24.0% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -36.8% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | STTK | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.4 | 弱 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$25.0K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
6.5%
下次报告
十一月 04, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 12, 2026 | $-0.12 | $-0.12 | -0.25% |
| 2026年3月31日 | 五月 13, 2026 | $-0.13 | $-0.14 | 7.7% |
| 2025年12月31日 | $-0.12 | $-0.14 | 13.9% | |
| 2025年9月30日 | $-0.14 | $-0.15 | 7.7% | |
| 2025年6月30日 | $-0.24 | $-0.25 | 4.0% | |
| 2025年3月31日 | $-0.27 | $-0.29 | 5.9% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $6M | $2M | $652.0K | $30M | $10M | $10M | |
| R&D Expense | $35M | $67M | $74M | $83M | $57M | $37M | $29M | |
| SG&A Expense | $17M | $19M | $19M | $21M | $19M | $9M | $6M | |
| Operating Expenses | $53M | $86M | $94M | $104M | $75M | $47M | $35M | |
| Operating Income | $-52M | $-81M | $-92M | $-103M | $-45M | $-37M | $-25M | |
| Interest Income | $3M | $5M | $5M | $2M | $625.0K | $549.0K | $1M | |
| Other Non-op | $-4.0K | $-17.0K | $-10.0K | $-208.0K | $-330.0K | $-221.0K | $-99.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | $-24M | |
| EPS (Basic) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| EPS (Diluted) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| Shares (Basic) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| Shares (Diluted) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| EBITDA | $-48M | · | $-88M | $-100M | $-44M | $-36M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $57M | $126M | $47M | $92M | $158M | $7M | |
| Prepaid Expense | $4M | $6M | $13M | $23M | $19M | $10M | $3M | |
| Current Assets | $82M | $79M | $143M | $185M | $288M | $346M | $42M | |
| PP&E (Net) | $6M | $10M | $14M | $18M | $10M | $3M | $2M | |
| PP&E (Gross) | $23M | $23M | $23M | $23M | $13M | $4M | $3M | |
| Accum. Depreciation | $17M | $13M | $10M | $6M | $3M | $1M | $862.0K | |
| Other Non-current Assets | $1M | $2M | $3M | $3M | $381.0K | $349.0K | $90.0K | |
| Total Assets | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Accounts Payable | $2M | $2M | $2M | $7M | $10M | $2M | $3M | |
| Current Liabilities | $7M | $9M | $11M | $25M | $25M | $17M | $20M | |
| Capital Leases | $2M | $3M | $3M | $4M | $0 | · | · | |
| Total Liabilities | $9M | $11M | $15M | $29M | $27M | $39M | $30M | |
| Common Stock | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $1.0K | |
| Paid-in Capital | $513M | $461M | $451M | $396M | $389M | $382M | $887.0K | |
| Retained Earnings | $-431M | $-382M | $-306M | $-219M | $-117M | $-72M | $-35M | |
| AOCI | $6.0K | $2.0K | $4.0K | $-877.0K | $-560.0K | $-63.0K | $54.0K | |
| Stockholders' Equity | $82M | $80M | $145M | $176M | $272M | $310M | $-35M | |
| Liabilities + Equity | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Shares Outstanding | 63,279,843 | 47,714,708 | 47,260,108 | 42,390,586 | 42,338,898 | 41,767,431 | 7,600,877 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $1M | $600.0K | $500.0K | |
| Stock-based Comp | $7M | $10M | $7M | $6M | $5M | $1M | $461.0K | |
| Other Non-cash | $-2M | · | $-5M | $-2M | $-19M | $1M | · | |
| Operating Cash Flow | $-40M | $-61M | $-81M | $-94M | $-57M | $-34M | $-21M | |
| CapEx | $71.0K | $59.0K | $407.0K | $12M | $8M | $727.0K | $470.0K | |
| Investing Cash Flow | $-8M | $-9M | $111M | $49M | $-10M | $-146M | $-4M | |
| Stock Issued | $44M | · | $48M | $0 | · | · | · | |
| Net Stock Activity | $44M | · | $48M | · | · | · | · | |
| Financing Cash Flow | $45M | $787.0K | $49M | $171.0K | $2M | $331M | $-64.0K | |
| Net Change in Cash | $-3M | $-68M | $78M | $-45M | $-66M | $151M | $-25M | |
| Free Cash Flow | $-40M | · | $-82M | $-106M | $-65M | $-34M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5150.8% | · | -5549.6% | -15848.0% | -150.8% | -371.8% | · | |
| Net Margin | -4880.9% | · | -5268.4% | -15635.7% | -149.8% | -368.5% | · | |
| EBITDA Margin | -4780.8% | · | -5308.2% | -15372.6% | -146.2% | -365.7% | · | |
| ROA | -53.6% | · | -47.9% | -40.5% | -13.9% | -18.6% | · | |
| ROE | -70.0% | · | -67.8% | -54.3% | -16.9% | -29.1% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | · | 12.5 | 7.4 | 11.7 | 20.5 | · | |
| Quick Ratio | 7.7 | · | 11.0 | 1.9 | 3.8 | 9.4 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.1 | 0.1 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.30 | · | $3.06 | $4.16 | $6.42 | $7.42 | · | |
| Revenue / Share | $0.01 | · | $0.04 | $0.02 | $0.71 | · | · | |
| Cash Flow / Share | $-0.57 | · | $-1.91 | $-2.23 | $-1.36 | · | · | |
| Cash / Share | $0.86 | · | $2.66 | $1.12 | $2.18 | $3.78 | · | |
| EPS (TTM) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -82.5% | 245.3% | 154.1% | -97.8% | 202.2% | · | · | |
| Revenue CAGR 3Y | 15.3% | -42.4% | -45.0% | · | · | · | · | |
| Revenue CAGR 5Y | -36.8% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $6M | $2M | $652.0K | $30M | $10M | · | |
| Net Income TTM | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | · | |
| Market Cap | $231M | · | $337M | $97M | $360M | $2.19B | · | |
| P/E | -5.2 | -0.8 | -3.5 | -1.0 | -8.0 | -22.2 | · | |
| P/S | 231.0 | · | 203.4 | 149.5 | 12.0 | 220.4 | · | |
| P/B | 2.8 | · | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Tangible Book | 2.8 | 0.7 | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Cash Flow | -5.8 | · | -4.1 | -1.0 | -6.3 | -65.0 | · | |
| P / FCF | -5.8 | · | -4.1 | -0.9 | -5.5 | -63.7 | · | |
| Earnings Yield | -19.2% | -123.1% | -28.7% | -104.8% | -12.6% | -4.5% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $3M | $2M | $1M | $714.0K | $686.0K | $200.0K | $57.0K | $390.0K | $212.0K | |
| R&D Expense | $12M | $11M | $9M | $8M | $9M | $10M | $15M | $16M | $19M | $16M | $15M | $24M | $18M | $17M | $22M | $19M | |
| SG&A Expense | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $7M | |
| Operating Expenses | $16M | $16M | $13M | $12M | $13M | $14M | $20M | $21M | $25M | $21M | $20M | $29M | $23M | $22M | $27M | $25M | |
| Operating Income | $-16M | $-16M | $-13M | $-11M | $-13M | $-14M | $-20M | $-18M | $-23M | $-20M | $-19M | $-29M | $-23M | $-22M | $-26M | $-25M | |
| Interest Income | $1M | $779.0K | · | · | $804.0K | $689.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-26.0K | $-1.0K | $-2M | $660.0K | $-230.0K | $-2.0K | $-4M | $1M | $1M | $2M | $-3M | $1M | $1M | $937.0K | $-727.0K | $594.0K | |
| Net Income | $-15M | $-15M | $-13M | $-10M | $-12M | $-14M | $-19M | $-17M | $-22M | $-19M | $-18M | $-28M | $-21M | $-21M | $-25M | $-25M | |
| EPS (Basic) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| EPS (Diluted) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| Shares (Basic) | 129,779,297 | 112,234,551 | · | 72,184,818 | 51,002,247 | 50,965,815 | · | 50,833,538 | 50,791,241 | 50,566,394 | · | 42,477,642 | 42,467,664 | 42,439,204 | · | 42,386,470 | |
| Shares (Diluted) | 129,779,297 | 112,234,551 | · | 72,184,818 | 51,002,247 | 50,965,815 | · | 50,833,538 | 50,791,241 | 50,566,394 | · | 42,477,642 | 42,467,664 | 42,439,204 | · | 42,386,470 | |
| EBITDA | $-16M | $-16M | · | $-11M | $-13M | $-14M | · | $-18M | $-23M | $-20M | · | $-29M | $-23M | $-22M | · | $-25M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $90M | $54M | $43M | $50M | $61M | $57M | $44M | $61M | $76M | $126M | $41M | $72M | $66M | $47M | $40M | |
| Prepaid Expense | $5M | $3M | $4M | $5M | $4M | $6M | $6M | $9M | $9M | $16M | $13M | $12M | $19M | $22M | $23M | $16M | |
| Current Assets | $213M | $94M | $82M | $91M | $55M | $66M | $79M | $99M | $114M | $131M | $143M | $113M | $136M | $158M | $185M | $202M | |
| PP&E (Net) | $5M | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $14M | $15M | $16M | $17M | $18M | $18M | |
| PP&E (Gross) | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $13M | · | · | · | $10M | · | · | · | $6M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Accounts Payable | $4M | $1M | $2M | $1M | $475.0K | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $5M | $7M | $3M | |
| Current Liabilities | $8M | $4M | $7M | $5M | $5M | $7M | $9M | $12M | $15M | $14M | $11M | $14M | $13M | $16M | $25M | $19M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $10M | $6M | $9M | $7M | $7M | $10M | $11M | $15M | $18M | $18M | $15M | $18M | $17M | $20M | $29M | $24M | |
| Common Stock | $10.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $672M | $541M | $513M | $511M | $465M | $463M | $461M | $460M | $457M | $454M | $451M | $401M | $400M | $398M | $396M | $394M | |
| Retained Earnings | $-460M | $-445M | $-431M | $-418M | $-408M | $-395M | $-382M | $-363M | $-346M | $-325M | $-306M | $-289M | $-261M | $-240M | $-219M | $-194M | |
| AOCI | $-63.0K | $0 | $6.0K | $3.0K | $1.0K | $0 | $2.0K | $52.0K | $-5.0K | $-14.0K | $4.0K | $7.0K | $-74.0K | $-339.0K | $-877.0K | $-1M | |
| Stockholders' Equity | $211M | $96M | $82M | $93M | $57M | $68M | $80M | $97M | $111M | $129M | $145M | $113M | $138M | $158M | $176M | $199M | |
| Liabilities + Equity | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Shares Outstanding | 100,726,022 | 75,581,787 | 63,279,843 | 63,151,789 | 47,903,215 | 47,899,240 | 47,714,708 | 47,739,708 | 47,727,269 | 47,519,219 | 47,260,108 | 42,485,485 | 42,471,335 | 42,460,258 | 42,390,586 | 42,390,586 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-10M | $-13M | $-8M | $-9M | $-10M | $-12M | $-17M | $-16M | $-11M | $-16M | $-19M | $-17M | $-19M | $-26M | $-24M | $-28M | |
| CapEx | · | · | $0 | $71.0K | · | · | $0 | $42.0K | $17.0K | $0 | $17.0K | $19.0K | $296.0K | $75.0K | $693.0K | $750.0K | |
| Investing Cash Flow | $-145M | $24M | $20M | $-43M | $0 | $16M | $31M | $-821.0K | $-5M | $-33M | $56M | $-15M | $24M | $45M | $31M | $30M | |
| Stock Issued | $80M | $21M | $-5.0K | $44M | $0 | $0 | · | $0 | · | · | · | $0 | · | · | · | · | |
| Net Stock Activity | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $128M | $26M | $134.0K | $44M | $0 | $-57.0K | $-72.0K | $23.0K | $1M | $-184.0K | $49M | $21.0K | $33.0K | $0 | $0 | $27.0K | |
| Net Change in Cash | $-27M | $36M | $12M | $-8M | $-10M | $4M | $14M | $-17M | $-15M | $-50M | $85M | $-31M | $6M | $19M | $8M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $-27M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| Net Margin | · | · | · | -1005.6% | · | · | · | -556.4% | -1339.5% | -1659.6% | · | -4014.7% | -10673.0% | -36357.9% | · | -11620.3% | |
| EBITDA Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| ROA | -10.6% | -16.5% | · | -9.5% | -12.9% | -12.3% | · | -13.8% | -15.2% | -11.4% | · | -15.6% | -10.5% | -9.2% | · | -9.2% | |
| ROE | -11.3% | -18.1% | · | -10.6% | -14.9% | -14.0% | · | -15.9% | -17.3% | -12.9% | · | -17.6% | -11.8% | -10.2% | · | -10.7% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.6 | 22.1 | · | 17.0 | 10.2 | 9.1 | · | 8.0 | 7.6 | 9.1 | · | 8.0 | 10.5 | 9.9 | · | 10.5 | |
| Quick Ratio | 8.2 | 21.3 | · | 8.0 | 9.5 | 8.3 | · | 3.5 | 4.0 | 5.3 | · | 2.9 | 5.5 | 4.1 | · | 2.1 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.10 | $1.27 | · | $1.48 | $1.19 | $1.41 | · | $2.02 | $2.32 | $2.71 | · | $2.65 | $3.26 | $3.71 | · | $4.70 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.01 | $0.00 | $0.00 | · | $0.06 | $0.03 | $0.02 | · | $0.02 | $0.00 | $0.00 | · | $0.01 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.24 | · | · | · | $-0.32 | · | · | · | $-0.62 | · | · | |
| Cash / Share | $0.63 | $1.20 | · | $0.67 | $1.05 | $1.27 | · | $0.92 | $1.27 | $1.60 | · | $0.96 | $1.69 | $1.56 | · | $0.94 | |
| EPS (TTM) | $-0.44 | $-0.56 | · | $-1.02 | $-1.21 | $-1.39 | · | $-1.53 | $-1.85 | $-1.93 | · | $-2.24 | $-2.17 | $-2.32 | · | $-1.63 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $3M | $5M | · | $6M | $4M | $3M | · | $1M | $859.0K | $709.0K | · | $30M | |
| Net Income TTM | $-53M | $-50M | · | $-55M | $-62M | $-71M | · | $-74M | $-85M | $-85M | · | $-95M | $-92M | $-98M | · | $-69M | |
| Market Cap | $699M | $486M | · | $151M | $38M | $46M | · | $167M | $184M | $425M | · | $65M | $133M | $125M | · | $114M | |
| P/E | -15.8 | -11.5 | · | -2.3 | -0.7 | -0.7 | · | -2.3 | -2.1 | -4.6 | · | -0.7 | -1.4 | -1.3 | · | -1.7 | |
| P/S | 699.0 | 486.0 | · | 150.9 | 12.7 | 9.9 | · | 25.9 | 44.7 | 156.5 | · | 48.4 | 154.3 | 176.1 | · | 3.8 | |
| P/B | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Tangible Book | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -36.2 | · | · | · | -3.8 | · | · | · | -26.3 | · | · | · | -4.7 | · | · | |
| Earnings Yield | -6.3% | -8.7% | · | -42.7% | -152.8% | -146.3% | · | -43.8% | -47.9% | -21.6% | · | -147.4% | -69.5% | -78.9% | · | -60.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $1M | $6M | $2M | $652.0K | $30M |
| 营业利润率 % | -5150.8% | · | -5549.6% | -15848.0% | -150.8% |
| 净收入 | $-49M | $-75M | $-87M | $-102M | $-45M |
| 稀释后每股收益 (EPS) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 11.7 | · | 12.5 | 7.4 | 11.7 |
| 速动比率 | 7.7 | · | 11.0 | 1.9 | 3.8 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-40M | · | $-82M | $-106M | $-65M |
机构持有人 (13F) 113 家申报者 · $483.8M 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
113
持有价值
$483.8M
新仓位
45
已退出持仓
18
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 45 (+20 与上一季度对比) | 18 (+14 与上一季度对比) | 35 (+4 与上一季度对比) | 14 (0 与上一季度对比) | +29.4M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56367922 | 8122179 | 11.65% | 股份 |
| Redmile Group, LLC | $47830709 | 6892033 | 9.89% | 股份 |
| ORBIMED ADVISORS LLC | $43764521 | 6306127 | 9.05% | 股份 |
| Prosight Management, LP | $41347666 | 5957877 | 8.55% | 股份 |
| BlackRock, Inc. | $27314521 | 3935810 | 5.65% | 股份 |
| Frazier Life Sciences Management, L.P. | $26025000 | 3750000 | 5.38% | 股份 |
| NEXTBio Capital Management LP | $25867795 | 3727348 | 5.35% | 股份 |
| Deep Track Capital, LP | $25724734 | 3706734 | 5.32% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $22262583 | 3207865 | 4.60% | 股份 |
| PINNACLE ASSOCIATES LTD | $12987807 | 1871442 | 2.68% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $12269490 | 1767938 | 2.54% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $11000534 | 1584756 | 2.27% | 股份 |
| CLARK ESTATES INC/NY | $9925359 | 1430167 | 2.05% | 股份 |
| Aberdeen Group plc | $9756606 | 1405851 | 2.02% | 股份 |
| VANGUARD GROUP INC | $8678773 | 2377746 | 1.79% | 股份 |
| Point72 Asset Management, L.P. | $8124880 | 1170732 | 1.68% | 股份 |
| 683 Capital Management, LLC | $8031079 | 1157216 | 1.66% | 股份 |
| STATE STREET CORP | $7123174 | 1026394 | 1.47% | 股份 |
| Boxer Capital Management, LLC | $6940000 | 1000000 | 1.43% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6572076 | 946985 | 1.36% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $5161701 | 743761 | 1.07% | 股份 |
| GOLDMAN SACHS GROUP INC | $4117668 | 593324 | 0.85% | 股份 |
| TD Asset Management Inc | $3878599 | 558876 | 0.80% | 股份 |
| NORTHERN TRUST CORP | $3610993 | 520316 | 0.75% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $3216100 | 463415 | 0.66% | 股份 |
| S&G Foundation | $3024098 | 435749 | 0.63% | 股份 |
| ALGERT GLOBAL LLC | $2923038 | 421187 | 0.60% | 股份 |
| FMR LLC | $2724616 | 392596 | 0.56% | 股份 |
| DEUTSCHE BANK AG\ | $2474305 | 356528 | 0.51% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2131968 | 307200 | 0.44% | 买入期权 |
| Connor, Clark & Lunn Investment Management Ltd. | $1988234 | 286489 | 0.41% | 股份 |
| Hillsdale Investment Management Inc. | $1828121 | 263418 | 0.38% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1575873 | 227071 | 0.33% | 股份 |
| Bank of New York Mellon Corp | $1516424 | 218505 | 0.31% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1395634 | 201100 | 0.29% | 卖出期权 |
| Caption Management, LLC | $1388000 | 200000 | 0.29% | 买入期权 |
| MILLENNIUM MANAGEMENT LLC | $1346416 | 194008 | 0.28% | 股份 |
| West Tower Group, LLC | $1329878 | 191625 | 0.27% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1317899 | 189899 | 0.27% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $1290472 | 185947 | 0.27% | 股份 |
| MORGAN STANLEY | $1261081 | 181712 | 0.26% | 股份 |
| TAKEDA PHARMACEUTICAL CO LTD | $1232329 | 515619 | 0.25% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $1080156 | 155642 | 0.22% | 股份 |
| XTX Topco Ltd | $650653 | 93754 | 0.13% | 股份 |
| TWO SIGMA ADVISERS, LP | $622690 | 170600 | 0.13% | 股份 |
| Jump Financial, LLC | $616272 | 88800 | 0.13% | 股份 |
| SPHERA FUNDS MANAGEMENT LTD. | $600039 | 86461 | 0.12% | 股份 |
| Nuveen, LLC | $565069 | 81422 | 0.12% | 股份 |
| LBJ Family Wealth Advisors, Ltd. | $560000 | 82177 | 0.12% | 股份 |
| Pathstone Holdings, LLC | $513255 | 73956 | 0.11% | 股份 |
激进投资者及 5%+ 股东 4 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, Redmile Biopharma Investments II, L.P. ×7 申报 | 2026年7月17日 | 9.90% | 修订 | · | SEC |
| ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC ×2 申报 | 2026年6月15日 | 9.99% | 修订 | · | SEC |
| JOSIAH HORNBLOWER ×2 申报 | 2022年12月9日 | · | 初始申报 | 被动投资 | SEC |
| Taylor Schreiber, M.D., Ph.D. | 2020年10月23日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 18 位内幕人士 · 7 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Taylor Schreiber | Chief Executive Officer | 2026年5月12日 M | 122222 | 0 | 0 | $0 |
| Andrew R Neill | Chief Financial Officer | 2026年5月12日 M | 292251 | 0 | 0 | $0 |
| Abhinav A. Shukla | Chief Technical Officer | 2026年7月6日 M | 98533 | 0 | 4 | $-183249 |
| Arundathy N. Pandite | Chief Medical Officer | 2026年6月30日 S | 136219 | 0 | 2 | $-408600 |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer | 2026年5月15日 M | 93366 | 0 | 0 | $0 |
| Casi Deyoung | Chief Business Officer | 2026年1月25日 F | 73480 | 0 | 0 | $0 |
| Erin Ator Thomson | General Counsel | 2023年1月25日 A | 103209 | 0 | 0 | $0 |
| Mona Ashiya | 董事 | 2026年6月11日 P | 1051021 | 0 | 0 | $0 |
| Clay B Siegall | 董事 | 2026年6月9日 P | 318608 | 1 | 0 | $250000 |
| Daniel G. Baker | 董事 | 2026年5月29日 A | · | 0 | 0 | $0 |
| Helen M Boudreau | 董事 | 2026年5月29日 A | · | 0 | 0 | $0 |
| George Golumbeski | 董事 | 2026年5月29日 A | 54613 | 0 | 0 | $0 |
| Neil W Gibson | 董事 | 2026年5月29日 A | · | 0 | 0 | $0 |
| Amy Kate Sasser | 董事 | 2025年7月14日 A | · | 0 | 0 | $0 |
| Carrie Brownstein | 董事 | 2025年7月14日 A | · | 0 | 0 | $0 |
| Tyler Brous | 董事 | 2025年7月14日 A | 238088 | 0 | 0 | $0 |
| Michael Stewart Lee | 董事 | 2025年7月14日 A | · | 0 | 0 | $0 |
| Josiah Hornblower | 董事 | 2021年7月15日 S | 2966709 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 15 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IWC · iShares Trust | 0.09% | 208976 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.02% | 501709 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 57611 SH | 2026年8月19日 | 每日 |
| RSSL · Global X Funds | 0.01% | 29182 NS | 2026年7月31日 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 50155 SH | 2026年10月2日 | 每日 |
| IWM · iShares Trust | 0.01% | 1581833 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 767988 SH | 2026年8月19日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 353062 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.01% | 153549 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 49623 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2366616 SH | 2026年8月19日 | 每日 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6884 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5109 SH | 2026年8月19日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.00% | 2719 NS | 2026年7月31日 | N-PORT |
| IWN · iShares Trust | · | 96671 SH | 2026年9月11日 | 每日 |
STTK 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 17 位分析师
买入
中位数目标
$15.00
+122.9%
6 35.3%
强烈买入
10 58.8%
买入
1 5.9%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-02平均目标 $15.00 +122.9%
← 低于所有目标
当前价格 $6.73
最低$10.00
平均值$15.00
最高$18.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 11, 2026 申报